These three small companies are dreaming big. Each aims to make a major impact in a different disease state. If...

Many studies have shown that the number one factor in producing outsize return on investment is the original purchase price...

Wall Street Analyst Nick Ackerman writes about closed end funds and income yielding plays on Seeking Alpha. Lately Mr. Ackerman...

Up and coming Wall Street analyst Kody Kester makes the case for Amgen. Strong Cash Flow, affordable valuation, and a...

Brad J. Schmier earned his PhD in biochemistry and molecular biology from the University of Miami specializing in RNA degradation....

Every once in a while, one key understanding pushes biology forward at warp speed. Many believe that we have arrived...

In science, a catalyst is an additive that causes a chemical reaction to occur. A catalyst is introduced to a...

Nonalcoholic steatohepatitis (NASH) is fat in the liver, with inflammation and damage. This “silent killer” is one of the leading...

As the philosopher Plato used to say, “Necessity is the Mother of Invention.” In the case of Biotech giants, if...

The past few days have been trying times for the global Alzheimer’s community. Biogen and Eisai Inc were forced to...